Tim Hagenacker

52PUBLICATIONS
178CO-AUTHORS
Applied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Gene and molecular therapyAllergyMedical devicesNeurology and neuromuscular diseases
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (52)

|Sep 10, 2026
Practical Guidance on Initiating and Switching Targeted Immunotherapies in Generalised Myasthenia Gravis: A German-Austrian Expert Opinion Paper.

|Aug 12, 2026
Disease modifying treatment of hereditary transthyretin amyloidosis with polyneuropathy in Germany - expert consensus of the German society of amyloid diseases (DGAK) and the German neurological society (DGN).

|Jul 06, 2026
Phenotype, Severity, and Therapy of Patients With LRP4 Antibody-Associated Myasthenia Gravis in the German Myasthenia Gravis Registry.

|Jun 17, 2026
Reverse engineering of BNIP3 identifies a mitochondrial protective peptide.

|Apr 15, 2026
Complement Inhibition Therapy in Myasthenic Crisis-A Multicentre Retrospective Analysis of 17 Cases From Germany.

Lea Gerischer, Maike Stein, Alice Schneider

|Jan 16, 2026
Choosing the optimal mouse model for the study of late-onset spinal muscular atrophy: Why the 4-copy SMN2 model offers ideal translational relevance.

Markus Leo, Linda-Isabell Schmitt, Kai Christine Liebig

Pageof 9

Frequent Collaborators

14 joint publications

Benjamin Stolte

11 joint publications

Christoph Kleinschnitz

8 joint publications

Paul Lingor

8 joint publications

Alma Osmanovic